Vanguard Global Advisers
SGHT icon

Vanguard Global Advisers’s Sight Sciences SGHT Stock Holding History

Vanguard Global Advisers’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.7K Hold
13,592
– – ﹤0.01% 2926
2026
Q1 		$51.2K Buy
+13,592
New +$73.4K ﹤0.01% 3008

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Global Advisers's SGHT Position: Q2 2026 in Review

Vanguard Global Advisers held its Sight Sciences (SGHT) position steady in Q2 2026 at 13,592 shares worth $73.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2926.

Vanguard Global Advisers first reported a position in SGHT in Q1 2026 and has held it in 2 quarters since. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Vanguard Global Advisers held 13,592 shares of Sight Sciences worth $73.7K as of Q2 2026.
  • Vanguard Global Advisers left its Sight Sciences share count unchanged in Q2 2026.
  • Sight Sciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2926 holding.
  • Vanguard Global Advisers first reported a position in Sight Sciences in Q1 2026 and has held it in 2 quarters since.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.